đ„đ BizChicken đđ„
Companies Similar to Myriad Genetics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Co-Diagnostics, Inc.
PCR diagnostic tests
Co-Diagnostics, Inc. develops, manufactures, and sells reagents for diagnostic tests that detect nucleic acid molecules, offering PCR tests for various diseases including COVID-19 and providing molecular diagnostic tools for healthcare and agricultural applications.
Symbol: CODX
Recent Price: $0.70
Industry: Medical - Devices
CEO: Mr. Dwight H. Egan
Sector: Healthcare
Employees: 155
Address: 2401 South Foothill Drive, Salt Lake City, UT 84109
Phone: 801 438 1036
Last updated: 2024-12-31
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
MacroGenics, Inc.
MARGENZA (margetuximab-cmkb)
Macro Genics, Inc. is a biopharmaceutical company that develops and commercializes antibody-based therapeutics to treat cancer, including the approved product MARGENZA for metastatic HER2-positive breast cancer and a pipeline of immuno-oncology candidates.
About | Vision/Values | About | Contact | ESG | Contact | Contact | Careers | Benefits | About
Symbol: MGNX
Recent Price: $3.23
Industry: Biotechnology
CEO: Dr. Scott Koenig M.D., Ph.D.
Sector: Healthcare
Employees: 339
Address: 9704 Medical Center Drive, Rockville, MD 20850
Phone: 301 251 5172
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Fulgent Genetics, Inc.
Genetic and Diagnostic Testing Services
Fulgent Genetics, Inc. provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the US and internationally, including genetic tests, oncology panels, carrier screening, and whole exome sequencing.
Symbol: FLGT
Recent Price: $18.42
Industry: Medical - Diagnostics & Research
CEO: Mr. Ming Hsieh
Sector: Healthcare
Employees: 1184
Address: 4978 Santa Anita Avenue, Temple City, CA 91780
Phone: 626 350 0537
Last updated: 2024-12-31
Cardio Diagnostics Holdings, Inc.
Epi+Gen CHD
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease, offering products like Epi+Gen CHD to assess risk and personalize care using AI and precision epigenetics.
Symbol: CDIO
Recent Price: $0.82
Industry: Biotechnology
CEO: Dr. Meeshanthini V. Dogan Ph.D.
Sector: Healthcare
Employees: 7
Address: 400 N Aberdeen St, Chicago, IL 60642
Phone: 855 226 9991
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Fresh2 Group Limited
Multi-cancer screening and detection tests
Fresh2 Group Limited is a biotechnology company specializing in cancer screening and detection technologies, offering products and services such as genetic testing kits, skin-care products, and technology services in China. It also operates an e-commerce platform for food supply connections.
Symbol: FRES
Recent Price: $1.08
Industry: Biotechnology
CEO: Mr. Haohan Xu
Sector: Healthcare
Employees: 75
Address: 650 5th Ave, New York, NY 10019-6108
Phone: N/A
Last updated: 2024-11-08
Illumina, Inc.
Sequencing and Array-based Solutions
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. It serves various markets, enabling genomic solutions in research and clinical settings for life sciences, oncology, and more.
About | About | Locations | Leadership | Directors | About | About | ESG | About | News | News | News | News | News | ESG | ESG | ESG | ESG | ESG | DEI | ESG | ESG | About | About | About | About | Contact | About | About | Contact | About | About | About | About | About | News | About | Careers | Jobs | Careers | Careers | Locations | Careers | Jobs | Jobs | Culture | Jobs | Jobs | Jobs | Jobs | About | Jobs | Careers | About | About | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Leadership | Careers | Careers | Locations | Locations | Locations | About | About | About | About | About | About | Careers | Jobs | About
Symbol: ILMN
Recent Price: $133.57
Industry: Medical - Diagnostics & Research
CEO: Mr. Jacob Thaysen Ph.D.
Sector: Healthcare
Employees: 10590
Address: 5200 Illumina Way, San Diego, CA 92122
Phone: 858 202 4500
Leadership
- Jacob Thaysen, PhD, Chief Executive Officer
- Steve Barnard, PhD, Chief Technology Officer
- Nicole Berry, Head of RegionâAmericas
- Todd Christian, Head of Services, Arrays, and Genomics Access
- Everett Cunningham, Chief Commercial Officer
- Scott Davies, Interim General Counsel
- Ankur Dhingra, Chief Financial Officer
- Pat Leckman, Chief People Officer
- Kevin Pegels, Chief of Global Operations
- Carissa Rollins, Chief Information Officer
- Salli Schwartz, Vice President of Investor Relations
- Bas Verhoef, Head of RegionâEurope
- Jakob Wedel, Chief Strategy and Corporate Development Officer
- Gretchen Weightman, Head of RegionâAsia Pacific, Middle East, and Africa
- Jenny Zheng, Head of RegionâGreater China
- Stephen P. MacMillan, Chair of the Board
- Frances Arnold, PhD, Director
- Caroline Dorsa, Director
- Robert S. Epstein, MD, Director
- Scott Gottlieb, MD, Director
- Gary S. Guthart, PhD, Director
- Anna Richo, Director
- Philip Schiller, Director
- Sue Siegel, Director
- Scott B. Ullem, Director
- Giovanna Prout, Associate Director, Product Marketing
- Jay Harger, Director, Clinical Genomics
Last updated: 2024-12-31
Inovio Pharmaceuticals, Inc.
DNA Medicines
Inovio Pharmaceuticals is a biotechnology company focused on discovering, developing, and commercializing DNA medicines to treat and protect against diseases like HPV, cancer, and infectious diseases. Their platform includes Syn Con designed DNA sequences and CELLECTRA smart devices technology for delivery.
Vision/Values | Leadership | About | Leadership | Vision/Values | About | Contact | Careers | Careers | About | About | About | About | About
Symbol: INO
Recent Price: $1.78
Industry: Biotechnology
CEO: Dr. Jacqueline E. Shea Ph.D.
Sector: Healthcare
Employees: 127
Address: 660 West Germantown Pike, Plymouth Meeting, PA 19462
Phone: 267 440 4200
Leadership
- Jacqueline Shea, Ph.D., President & Chief Executive Officer
- Peter Kies, Chief Financial Officer
- Michael Sumner, MB BS, MBA, Chief Medical Officer
- Laurent Humeau, Ph.D., Chief Scientific Officer; Chairman, Scientific Advisory Board
- Steve Egge, MBA, Chief Commercial Officer
- Rob Crotty, J.D., General Counsel and Chief Compliance Officer
- EJ Brandreth, MBA, Senior Vice President, Quality Assurance
- Shawn Bridy, MA, MBA, Senior Vice President, Business Development
- Cheryl Elder, PharmD, Senior Vice President, Regulatory Affairs
- Robert J. Juba Jr., Senior Vice President, Biological Manufacturing and Clinical Supply Management
- Jeffrey Skolnik, M.D., Senior Vice President, Clinical Development
- Dave Liebowitz, M.D. & Ph.D., Senior Vice President, Early-Stage Clinical Development
- Simon X. Benito, Chairman of the Board, Inovio Pharmaceuticals
- Roger D. Dansey, M.D., Chief Medical Officer at Seagen
- Ann C. Miller, M.D., Former Head of Sanofi Oncology Global Marketing
- Jay Shepard, Former President & CEO of Aravive
- David B. Weiner, Ph.D., Executive Vice President, Director, Vaccine Center, The Wistar Institute
- Wendy L. Yarno, MBA, Former Executive Vice President and Chief Marketing Officer at Merck & Co., Inc.
- Lota S. Zoth, CPA, Former Chief Financial Officer, MedImmune
- Rafi Ahmed, Ph.D., Director, Emory Vaccine Center, Emory University School of Medicine
- Stanley A. Plotkin, M.D., Emeritus Professor, Wistar Institute and University of Pennsylvania; Principal, Vaxconsult
Last updated: 2024-12-31
Myriad Genetics, Inc.
My Risk Hereditary Cancer Test
Myriad Genetics, Inc. is a genetic testing and precision medicine company that develops and commercializes genetic tests for oncology, women's health, and mental health applications.
Symbol: MYGN
Recent Price: $13.63
Industry: Medical - Diagnostics & Research
CEO: Mr. Paul J. Diaz
Sector: Healthcare
Employees: 2700
Address: 320 Wakara Way, Salt Lake City, UT 84108
Phone: 801 584 3600
Last updated: 2024-12-31
NeoGenomics, Inc.
Cancer-focused testing services
Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.
About | About | Leadership | Benefits | About | About | About | About | About | About | Contact | About | About | About
Symbol: NEO
Recent Price: $16.92
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher Michael Smith BSc
Sector: Healthcare
Employees: 2100
Address: 9490 NeoGenomics Way, Fort Myers, FL 33912
Phone: 239 768 0600
Leadership
- Chris Smith, Chief Executive Officer
- Jeff Sherman, Chief Financial Officer
- Warren Stone, Chief Commercial Officer
- Melody Harris, Chief Operations Officer & President, Informatics
- Ali Olivo, Executive Vice President, General Counsel & Business Development
- Hutan Hashemi, JD, Chief Compliance Officer
- Nathan Montgomery, MD, PhD, Vice President, Medical Services
- Gary Passman, Chief Culture Officer
- Kareem Saad, Head of Strategy and Transformation
- Lynn A. Tetrault, Chair of the Board
- Bruce K. Crowther, Board Member
- Elizabeth Floegel, Board Member
- Neil Gunn, Board Member
- Alison L. Hannah, MD, Board Member
- Stephen Kanovsky, Board Member
- Michael A. Kelly, Board Member
- David Perez, Board Member
- Tony Zook, Board Member
- Derek Lyle, MD, Chief Medical Officer
- Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
- J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
- Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
- Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
- Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
- Renuka Agrawal, MD, Senior Hematopathologist
- Todd S. Barry, MD PhD, Senior Hematopathologist
- Bora Baysal, MD, PhD, Senior Hematopathologist
- Saskia Boisot, MD, Senior Hematopathologist
- Wayne W. Chen, MD PhD, Director of Hematopathology Services
- Rachel Flamholz, MD, Senior Hematopathologist
- Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
- Anselm Hii, MD, Director of Hematopathology Services
- Thanh Ho, MD, Senior Hematopathologist
- Kim Janatpour, MD MA, Senior Hematopathologist
- Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
- Sameer S. Khatri, MD, Hematopathologist
- Madeleine Kraus, MD, Senior Hematopathologist
- Brian Kwok, MD FCAP, Corporate Director of Hematopathology
- Keming Lin, MD MS FCAP, Senior Hematopathologist
- Robert Lin, MD, Senior Hematopathologist
- Russell L. Maiese, M.D., Senior Hematopathologist
- Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
- Viera Nelson, MD, Senior Hematopathologist
- Dennis P. OâMalley, MD, Senior Hematopathologist
- Anthony Padula, MD, Senior Hematopathologist
- Munir Shahjahan, MD MPH, Senior Hematopathologist
- Jesalyn J. Taylor, MD, Senior Hematopathologist
- Jian-Feng Wang, MD PhD, Senior Hematopathologist
- Zhao Wu, MD PhD FCAP, Senior Hematopathologist
- Aine Yung, MD FCAP, Senior Hematopathologist
- Sadiq Zaman, MD, Senior Hematopathologist
- Guohua Zhao, MD PhD, Senior Hematopathologist
- Mitual Amin, MD, Senior Surgical Pathologist
- Jerry Chu, MD PhD, Senior Surgical Pathologist
- Ted Farzaneh, MD, Senior Surgical Pathologist
- Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
- Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
- Robert Schwartz, MD, Senior Surgical Pathologist
- Yae K (Kay) Suh, MD, Senior Surgical Pathologist
- Matthew Geller, DO, Molecular Pathologist
- Hao Ho, MD, Molecular Pathologist
- Jennifer Hummel, MD, Senior Molecular Pathologist
- Armen Kaysan, MD, Molecular Pathologist
- Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
- Saed Sadeghi, MD, Molecular Pathologist
- Ying Wang, MD PhD, Molecular Pathologist
- Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
- Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
- Indu Gupta, MD, Surgical Pathologist, Pharma Services
- Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
- Albert Ho, Director of Pharma Pathology Services
- Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
- Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
- Li Cheng, PhD FACMG, Associate Director of Cytogenetics
- Liang Dong, MD PhD, Director of Cytogenetic Services
- Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
- Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
- Fernando J. LĂłpez-DĂaz, PhD, Director of Clinical Science, Research and Development
- John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
- Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
- Farzad Nooraie, MD, Director of Cytogenetic Services
- RĂłisĂn Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
- Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
- Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
- Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
- Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
- Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
- John N. Allan, MD, Scientific Advisory Board Member
- Rafael Bejar, MD, PhD, Scientific Advisory Board Member
- James R. Berenson, MD, Scientific Advisory Board Member
- Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
- James Downing, MD, Scientific Advisory Board Member
- Bernard A Fox, PhD, Scientific Advisory Board Member
- Gregory Hess, MD, Scientific Advisory Board Member
- Hatim Husain, MD, Scientific Advisory Board Member
- Tibor Kovacsovics, MD, Scientific Advisory Board Member
- Razelle Kurzrock, MD, Scientific Advisory Board Member
- Gail J. Roboz, MD, Scientific Advisory Board Member
- Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
- Mark A. Rubin, MD, Scientific Advisory Board Member
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
Natera, Inc.
Panorama
Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services worldwide, offering various tests for prenatal screening, genetic disorders, and more.
Contact | About | Leadership | About | News | ESG | News | News | News | News | News | Careers | Careers | About | About | About | About | About | About | About | About | About | About | About | About | Careers | About | About | About | About
Symbol: NTRA
Recent Price: $158.55
Industry: Medical - Diagnostics & Research
CEO: Mr. Steven Leonard Chapman
Sector: Healthcare
Employees: 3282
Address: 13011 McCallen Pass Building A, San Carlos, CA 78753
Phone: 650 249 9090
Leadership
- Steve Chapman, Chief Executive Officer
- Mike Brophy, MBA, Chief Financial Officer
- Alexey Aleshin, MD, MBA, GENERAL MANAGER, ONCOLOGY AND ECD & CHIEF MEDICAL OFFICER
- Olesya Anisimova, CPA, Chief Accounting Officer
- Jerry Diffley, Chief Compliance and Privacy Officer
- Eric Evans, PhD, Chief Scientific Officer
- John Fesko, PRESIDENT, CHIEF BUSINESS OFFICER
- Ramesh Hariharan, PhD, MBA, General Manager, Women's Health
- Rishi Kacker, Chief Technology Officer
- J. Dianne Keen-Kim, PhD, FACMG, HCLD (ABB), CLIA Laboratory Director
- Chitra Kotwaliwale, PhD, SVP OF CLINICAL & COMMERCIAL OPERATIONS AND PORTFOLIO MANAGEMENT
- Solomon Moshkevich, MBA, PRESIDENT, CLINICAL DIAGNOSTICS
- Anu Pai, MS, Head of R&D Program Management
- Sheetal Parmar, MS, CGC, SVP of Medical Affairs, Womenâs Health
- Daniel Rabinowitz, LLM, Secretary & Chief Legal Officer
- Matthew Rabinowitz, PhD, Executive Chairman
- John Ryan, PhD, MBA, Chief Laboratory Officer
- Robert Schueren, Chief Operating Officer
- Bernie Tobin, MBA, General Manager, Organ Health
Last updated: 2024-12-31
OncoCyte Corporation
Determa Rx
Onco Cyte Corporation, based in Irvine, California, develops and commercializes molecular diagnostics tests for cancer detection, including Determa Rx and Determa IO.
Symbol: OCX
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Joshua Riggs
Sector: Healthcare
Employees: 43
Address: 15 Cushing, Irvine, CA 92618
Phone: 949 409 7600
Leadership
- Josh Riggs, President & Chief Executive Officer
- Prof. Dr. Ekkehard SchĂŒtz, MD, PhD, FAACC, Chief Science Officer
- Yuh-Min (Johnson) Chiang, PhD, Chief Technology Officer
- Andrea James, Chief Financial Officer
- Sandra OâDonald, Senior Vice President, Business Operations
- Ryan Andrews, Vice President, Commercial
- Peter Hong, Vice President, General Counsel
- James Liu, Senior Director, Controller & Principal Accounting Officer
Last updated: 2024-12-31
OpGen, Inc.
Acuitas AMR Gene Panel, ARES Technology Platform, Unyvero Platform
Op Gen, Inc. is a precision medicine company focused on developing and commercializing molecular microbiology solutions, including IVD tests for antimicrobial resistance and automated molecular diagnostics platforms.
About | Leadership | Directors | Contact | Contact | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: OPGN
Recent Price: $0.62
Industry: Medical - Diagnostics & Research
CEO: Mr. Honjian Tan
Sector: Healthcare
Employees: 85
Address: 9717 Key West Avenue, Rockville, MD 20850
Phone: 240 813 1260
Leadership
- John Tan Honjian, Chief Executive Officer and Chairman
- David E. Lazar, President
- David Caplon, Corporate Controller
- Christian-Laurent Bonte, Independent Director
- Victor Chua Kok Hoe, Independent Director
- Ken Lim Zhao Qi, Independent Director
- Ethan Low Yu Jie, Director
- Constance Wong Poh Yin, Director
Last updated: 2024-12-31
Predictive Oncology Inc.
Personalized Cancer Therapies
Predictive Oncology Inc. is a knowledge-driven company focusing on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States, operating in four segments: Helomics, z PREDICTA, Soluble, and Skyline.
Symbol: POAI
Recent Price: $0.90
Industry: Medical - Instruments & Supplies
CEO: Mr. Raymond F. Vennare
Sector: Healthcare
Employees: 34
Address: 2915 Commers Drive, Eagan, MN 55121
Phone: 651 389 4800
Last updated: 2024-12-31
Personalis, Inc.
NeXT Platform
Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.
About | Contact | Contact | Contact | Careers | Careers | Careers | About | About | Careers | About | About | About
Symbol: PSNL
Recent Price: $5.97
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher M. Hall
Sector: Healthcare
Employees: 223
Address: 1330 OâBrien Drive, Menlo Park, CA 94025
Phone: 650 752 1300
Last updated: 2024-12-31
Veracyte, Inc.
Afirma Genomic Sequencing Classifier, Xpression Atlas, Decipher Prostate, Prosigna Breast Cancer Assay, Percepta Genomic Sequencing Classifier, Envisia Genomic Classifier, Immunoscore Colon Cancer test
Veracyte, Inc. operates as a diagnostics company worldwide, providing genomic testing solutions for various cancers and diseases, aiming to improve outcomes by avoiding unnecessary surgeries and enhancing treatment decisions.
Symbol: VCYT
Recent Price: $40.00
Industry: Biotechnology
CEO: Mr. Marc A. Stapley
Sector: Healthcare
Employees: 815
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 243 6300
Last updated: 2024-12-31
IDEAYA Biosciences, Inc.
IDE397 and IDE196
IDEAYA Biosciences, Inc. is a precision medicine oncology company that focuses on developing targeted therapeutics for specific patient populations using molecular diagnostics. Key product candidates include IDE397 and IDE196, aimed at treating genetically defined cancers.
Symbol: IDYA
Recent Price: $24.93
Industry: Biotechnology
CEO: Mr. Yujiro S. Hata
Sector: Healthcare
Employees: 124
Address: 7000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 443 6209
Last updated: 2024-12-31